Small Interfering RNA Market Outlook:
Small Interfering RNA Market size was over USD 18.33 billion in 2025 and is projected to reach USD 67.36 billion by 2035, witnessing around 13.9% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of small interfering RNA is evaluated at USD 20.62 billion.
The reason behind the growth is impelled by rising cases of cancer across the globe. Small interfering RNA has been studied as an effective treatment for cancer as it targets specific mRNA and blocks abnormal gene expression that causes the disease. By 2040, there will be more than 26 million new instances of cancer worldwide.
The growing partnerships and collaborations are believed to fuel the market growth. For instance, in 2022 Alnylam Pharmaceuticals and Novartis came together to treat liver disease by using siRNA to suppress a Novartis-discovered target, which could lead to the regeneration of functional liver cells and advance the possibility for new drugs in a variety of illness conditions.
